These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11192857)

  • 1. Efavirenz-associated breast hypertrophy in HIV-infection patients.
    Mercié P; Viallard JF; Thiébaut R; Faure I; Rispal P; Leng B; Pellegrin JL
    AIDS; 2001 Jan; 15(1):126-9. PubMed ID: 11192857
    [No Abstract]   [Full Text] [Related]  

  • 2. Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz.
    Caso JA; Prieto Jde M; Casas E; Sanz J
    AIDS; 2001 Jul; 15(11):1447-8. PubMed ID: 11504970
    [No Abstract]   [Full Text] [Related]  

  • 3. Efavirenz-induced catatonia.
    Sabato S; Wesselingh S; Fuller A; Ray J; Mijch A
    AIDS; 2002 Sep; 16(13):1841-2. PubMed ID: 12218403
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of abacavir and efavirenz: new antiretroviral drugs to treat HIV-1 infection.
    Wolbach J; Capoccia K
    Nurse Pract; 1999 Jun; 24(6):81-2, 87-90, 92. PubMed ID: 10431297
    [No Abstract]   [Full Text] [Related]  

  • 5. NNRTI hepatotoxicity: efavirenz versus nevirapine.
    Pulido F; Torralba M
    J HIV Ther; 2002 Nov; 7 Suppl 2():S3-16. PubMed ID: 12735215
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efavirenz].
    Taéron C
    Rev Infirm; 2005 May; (111):37-8. PubMed ID: 15991644
    [No Abstract]   [Full Text] [Related]  

  • 7. Efavirenz-induced photoallergic dermatitis in HIV.
    Treudler R; Husak R; Raisova M; Orfanos CE; Tebbe B
    AIDS; 2001 May; 15(8):1085-6. PubMed ID: 11400003
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efavirenz--comprehensive status of studies].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():79-81. PubMed ID: 16385886
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection].
    van Leth F; Lange JM
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1719-22. PubMed ID: 16924943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelomeningocele in a child with intrauterine exposure to efavirenz.
    Fundarò C; Genovese O; Rendeli C; Tamburrini E; Salvaggio E
    AIDS; 2002 Jan; 16(2):299-300. PubMed ID: 11807320
    [No Abstract]   [Full Text] [Related]  

  • 11. Four-drug regimens may be better.
    AIDS Patient Care STDS; 2000 Dec; 14(12):671. PubMed ID: 11119435
    [No Abstract]   [Full Text] [Related]  

  • 12. Manic syndrome associated with efavirenz overdose.
    Blanch J; Corbella B; García F; Parellada E; Gatell JM
    Clin Infect Dis; 2001 Jul; 33(2):270-1. PubMed ID: 11418896
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply. Lest we forget: neuropsychiatry and the new generation anti-HIV drugs.
    Gonzalez A; Everall I
    AIDS; 1999 Oct; 13(14):1996. PubMed ID: 10513671
    [No Abstract]   [Full Text] [Related]  

  • 14. Switching from protease inhibitors to the non-nuke efavirenz.
    TreatmentUpdate; 2001; 12(12):3. PubMed ID: 11570089
    [No Abstract]   [Full Text] [Related]  

  • 15. Efavirenz for HIV-1 infection in adults: an overview.
    Fortin C; Joly V
    Expert Rev Anti Infect Ther; 2004 Oct; 2(5):671-84. PubMed ID: 15482231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting adherence and convenience in antiretroviral therapy.
    Lafeuillade A
    Int J STD AIDS; 2001 Nov; 12 Suppl 4():18-24. PubMed ID: 11589824
    [No Abstract]   [Full Text] [Related]  

  • 17. Female sex but not ethnicity is a strong predictor of non-nucleoside reverse transcriptase inhibitor-induced rash.
    Mazhude C; Jones S; Murad S; Taylor C; Easterbrook P
    AIDS; 2002 Jul; 16(11):1566-8. PubMed ID: 12131201
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance of efavirenz in children.
    Teglas JP; Quartier P; Treluyer JM; Burgard M; Gregoire V; Blanche S
    AIDS; 2001 Jan; 15(2):241-3. PubMed ID: 11216933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-nucleoside reverse transcriptase inhibitors--an overview.
    Bell C; Matthews GV; Nelson MR
    Int J STD AIDS; 2003 Feb; 14(2):71-7. PubMed ID: 12662384
    [No Abstract]   [Full Text] [Related]  

  • 20. [Didanosine--stability as backbone drug].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():83-4. PubMed ID: 16385888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.